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Abstract. Disinhibited activity of the hypothalamic-pituitary-adrenocortical 
(H PA) neuroendocrine system, characterized most specifically by abnormal 
responses to the dexamethasone suppression test (DST), is observed in 40-50% of 
patients with endogenous depression. The heterogeneity of endogenous depres- 
sives with respect to this neuroendocrine marker is so far unexplained. A recent 
report from Iowa suggested that genetic factors could account for this heteroge- 
neity, since abnormal DST responses were found with widely differing frequencies 
among primary unipolar depressives subtyped by the genetic criteria of Winokur. 
We studied 14 patients with primary endogenous delusional unipolar depression. 
Abnormal DST responses were found in 79% of the entire group, and with similar 
frequencies among each of the Winokur subtypes. In particular, five of six patients 
(83%) with depression spectrum disease had abnormal DST results. This contrasts 
with a frequency of 4% reported by the Iowa group. We conclude that disinhibited 
HPA activity does occur in depression spectrum disease when a delusional endo- 
genous depression is present. Our results and those ofthe Iowa study could both be 
consistent with a threshold model of HPA activation. The high frequency of 
positive DST results in delusional endogenous depressives may be determined by 
disinhibited central pain mechanisms. Variations in this clinical dimension, com- 
bined with variations in threshold for HPA activation by pain mechanisms, could 
account for the heterogeneity of DST responses among endogenous depressives. 
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The neuroendocrine research strategy has revealed several types of functional distur- 
bance in depressed patients, of which the best documented is disinhibition of the 
hypothalamic-pituitary-adrenocortical (HPA) system (Carroll, 1978). A consistent 
finding is that 40-50% of patients with endogenous depression have abnormal 
responses to the overnight dexamethasone suppression test (DST) (Carroll and Men- 
dels, 1976; Carroll, 1977; Carroll et al., 19766, in press; Brownet al., 1979; Schlesser et 
al., 1979). An important issue in this area is the heterogeneity of patients with 
endogenous depression with respect to this neuroendocrine marker. Attempts to 
distinguish convincingly between those with normal and abnormal DST responses by 
clinical features have been unsuccessful (Carroll and Davies, 1970; Carroll, 1972; 
Carroll et al., 19766; Brown et al., 1979; Schlesser et al., 1979). So far, only the clinical 
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discrimination between endogenous and nonendogenous (neurotic) depression has 
had strong predictive value for the DST response: Patients with nonendogenous 
depression have a very low frequency (< 4%) of positive DST results (Carroll et al., 
19766, in press). 
A recent study from Winokur’s group in Iowa described widely differing frequencies 
of positive DST results among genetic subtypes of patients with primary unipolar 
depression (Schlesser et al., 1979). The unipolar patients were classified according to 
the family history criteria of Winokur et al. (1978) into three subtypes: 1. Familial pure 
depressive disease-depression in a person who has a first-degree relative with a 
history of depression but not of mania, alcoholism, or antisocial personality. 2. 
Sporadic depressive disease-depression in a person with no first-degree relative with 
alcoholism, antisocial personality, or depression. 3. Depression spectrum disease- 
depression in a person who has a first-degree relative with alcoholism and/or antiso- 
cial personality, and who may or may not have a first-degree relative with depression. 
Abnormal DST results were found in 43% of the entire group. The frequencies were 
82% in those with familial pure depressive disease; 37% in those with sporadic 
depressive disease; and only 4% in those with depression spectrum disease. Since these 
three subtypes could not be distinguished by clinical features, the clear implication of 
this report is that genetic factors account for a major part of the heterogeneity 
observed in the DST results. The Winokur classification is not widely used in other 
centers, so no attempted replications of this study have yet appeared. In view of its 
potential importance, we have made a limited review of our own data to see whether 
we could support the study from lowa. 
Methods 
Since our routine family history evaluations are less rigorous than those obtained by 
the Iowa group, we could not be confident about assigning all our unipolar cases to 
their three subtypes. Therefore, we focused on a carefully documented group of 
patients with severe endogenous depression accompanied by affective delusions. The 
patients met the St. Louis criteria for primary unipolar depression (Feighner et al., 
1972) and also the Research Diagnostic Criteria for primary unipolar major depres- 
sive disorder, endogenous and psychotic subtypes (Spitzer and Endicott, 1975). In 
each case the diagnosis was confirmed by our own clinical assessments (Feinberget al., 
1979). We had extensive contacts with family members in these cases (all inpatients), 
and we obtained family psychiatric histories from at least one relative in addition to 
the patients themselves. 
Fourteen index cases with 28 ill relatives were identified, and the patients were 
classified according to the criteria of Winokur et al. (1978). All family history assess- 
ments were made by clinicians who were unaware of the DST results. For the critical 
diagnosis of alcoholism in the relatives, we had unequivocal descriptions of sustained 
abuse of alcohol, with functional impairment and adverse effects on family relation- 
ships. For sociopathy, only one first-degree relative met criteria. This person was 
described as having repeated arrests and trouble with the police, frequent charges of 
stealing goods, and an unstable occupational record. The diagnoses of depression in 
relatives were based on the descriptions given by the probands and at least one other 
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relative. We accepted only descriptions of depressions that were episodic and required 
treatment, or that were terminated by suicide. We did not accept descriptions that 
referred to the relative as having a lifelong depressive personality, as being “frequently 
nervous,” or as being admitted to the hospital “for nerves.” Thus, our diagnoses of 
alcoholism and sociopathy in relatives would meet the family history research dia- 
nostic criteria used by Schlesser et al. (1979). Most of our diagnoses of depression in 
relatives also would meet these criteria. With respect to the categories of key interest 
for this study, errors in the diagnosis of depression among relatives would not alter the 
result. Such errors would lead to some patients’ being reclassified only between the 
categories familial pure depressive disease and sporadic depressive disease. They 
would not lead to reclassification of relatives diagnosed as having depressive spectrum 
disease. 
The DST was performed as described previously (Carroll et al., 1976a, 1976b). 
Blood samples were obtained for plasma cortisol determination at 0800h, 1600h, and 
2300h after oral administration of dexamethasone (1 mg or 2 mg) at 2300h the 
preceding night. By comparison, Schlesser et al. (1979) obtained only one blood 
sample at 0800h, and they used a 1 mg dose of dexamethasone. 
In selecting this particular group of patients for study, we had one further methodo- 
logical issue in mind: The frequency of abnormal DST results is especially high among 
psychotic (delusional) endogenous depressive patients (Carroll et al., 19766). Thus, 
this population would present a very stringent test of the Iowa report, so that a 
confirmation of their findings in these patients would be strong support indeed. 
Results 
There were two cases subtyped as familial pure depressive disease, five as sporadic 
depressive disease, and six as depression spectrum disease. One patient (# 14) could not 
be classified since she had a daughter with bipolar manic-depressive illness (Table 1). 
Seven patients were male, and seven female, the median age at the time of study being 
60 years. Nine patients were experiencing at least the third episode of depression, two 
were in their second episode, and three were seen in their first episode. The mean ages 
of onset of episodes were: familial pure depressive disease, 47 years; sporadic depres- 
sive disease, 43 years; depression spectrum disease, 45 years. 
The family psychiatric histories obtained in these 14 patients are listed in Table 2, 
where both the first- and second-degree ill relatives are recorded. Two of the patients 
classified as sporadic depressive disease had definite second-degree family histories of 
alcoholism. A strong first-degree history of alcoholism was found in the unclassified 
patient (#14). By definition, all patients with depression spectrum disease had a 
first-degree history of alcoholism or sociopathy, and half of them also had a first- 
degree history of depression. 
The results of the DSTs among these patients with primary psychotic endogenous 
unipolar depression are shown in Table 3. Overall, 11 of the 14 patients (79%) had a 
positive test result. The frequency of positive tests was 50% in familial pure depressive 
disease, 80% in sporadic depressive disease, and 83% in depression spectrum disease. 
For this analysis we have used the plasma cortisol criterion level of 5 pg/dl, in keeping 
with Schlesser et al. (1979). When the analysis is restricted to the 0800h plasma cortisol 
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level (which was the only sample obtained by Schlesser et al.), then the frequency of 
abnormal results in the three genetic subtypes is: familial pure depressive disease, 0%; 
sporadic depressive disease, 60%; and depression spectrum disease, 60% (one missing 
case at 08OOh). 
Table 1. Characteristerics of 14 patients with primary psychotic endogenous 
unipolar depression 
Previous Age Winokur 
Patient Me Sex episodes at onset subtype 
1 68 M 4 62 FPDD 
2 51 M 4 31 FPDD 
3 52 F 3 42 SDD 
4 67 F 0 67 SDD 
5 28 F 0 28 SDD 
6 68 M 9 46 SDD 
7 31 F 0 30 SDD 
8 73 F 4 57 DSD 
9 66 F 1 54 DSD 
10 53 M 2 43 DSD 
11 62 M 4 47 DSD 
12 a3 M 4 47 DSD 
13 67 M 1 24 DSD 
14 73 F 3 24 
FPDD: familial pure depressive disease 
SDD: sporadic depressive disease. 
DSD: depression spectrum disease 
Discussion 
In this study the DST did not discriminate among the three familial subtypes of 
unipolar depressives. In particular, the patients with depression spectrum disease had 
a high frequency of abnormal test results. By the procedure of Schlesser et al. (1979) 
the frequency in this group was 60%, while with our own extended test procedure 
(Carroll et al., 1976~; 19766) it was 83%. Both these results are distinctly greater than 
the 4% frequency reported by Schlesser et al. (1979). 
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Table 2. Family psychiatric histories of 14 patients 
with primary psychotic endogenous unipolar 
deoression 
Winokur 















M,N depression and suicide 




PU, PU, PU alcoholic 
MGM alcoholic 
MA depression, ECT 
B alcoholic 








F,B, son alcoholic 
B depression 
D bipolar I manic-depressive 
B: brother; D: daughter; F: father; M: mother; N: niece; S: sister; 
MA: maternal aunt; MGM: maternal grandmother; PU: paternal untie; 
ECT: electroconvulsive therapy. 
The highly selected nature of our population (and its small size) must be kept in 
mind when our results are compared with those of the Iowa group. As noted earlier, a 
confirmation of their results with our psychotic depressive patients would have been 
very significant. The findings we report here, however, do not necessarily disprove the 
work of Schlesser et al. (I 979). Only a larger study of more typical patients would 
constitute a definitive attempt to replicate their work. Thus, the major conclusions we 
wish to draw from our present results are (1) abnormal DST responses certainly do 
occur in delusional patients with depression spectrum disease, and (2) the heteroge- 
neity of DST results among patients with endogenous depression cannot be accounted 
for by genetic factors alone. 
If the severity of illness in the patients reported here is considered, it may be possible 
to reconcile our results with those of Schlesser et al. (1979) by means of a threshold 
model for HPA activation. This model would propose that patients with depression 
spectrum disease have a higher threshold than the other subtypes do, so that abnormal 
DST results would not be found unless patients with very severe illness (such as our 
delusional cases) were examined. 
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Table 3. Results of overnight dexamethasone suppression tests in 14 patients 
with primary psychotic endogenous unipolar depression. 
Postdexamethasone 
Winokur Dexamethasone plasma cortisol (pg/dl) Abnormal 
subtype Patient dose (mg) 0800h 1800h 2300h test result 
FPDD 1 2 0.6 7.6 6.2 + 
FPDD 2 1 2.1 0.6 0.9 
SDD 3 1 1.7 17.8 11.0 t 
SDD 4 1 11.3 4.7 5.6 + 
SDD 5 1 5.3 4.1 3.3 + 
SDD 6 1 26.3 22.5 11.6 + 
SDD 7 2 0.7 1.2 0.6 
DSD a 1 0.7 1.2 4.1 
DSD 9 1 6.0 4.1 4.4 + 
DSD 10 1 14.1 9.2 - + 
DSD 11 2 - 4.2 15.9 + 
DSD 12 2 2.1 15.0 a.7 + 
DSD 13 1 a.3 15.5 14.5 + 
- 14 1 15.0 la.0 17.7 + 
All plasma cortisol levels should be c 5 @g/d1 for a normal result 
If this threshold model is correct, however, it would tend to go against the Iowa 
proposal that the three subtypes are “separate illnesses.” Since these three variants of 
unipolar depressive illness are not distinguishable clinically (Van Valkenburg et al., 
1977; Schlesser et al., 1979), they may indeed be the same affective disorder, but with 
genetically determined differences in their threshold for neuroendocrine activation. In 
fact, except for the DST finding of Schlesser et al. (1979), the Winokur classification 
has only weak support from two features, namely, age at onset and number of episodes 
(Winokur et al., 1978). Both of these could also be regarded as threshold functions. 
A threshold model of HPA activation could be useful also for understanding the 
very high frequency of abnormal DST results (almost double the usual rate) observed 
in all the delusional depressives. This finding is not related simply to the presence of 
psychosis, since other kinds of psychotic patients (schizophrenics) consistently have 
normal DST responses (Carroll et al., 1976b; Brown et al., 1979; Schlesser et al., 1979). 
Thus, the high frequency of neuroendocrine disturbance in psychotic depressives may 
be determined by the extreme severity of depressive symptoms and by the specific 
affective quality of their delusions. 
In this respect it can be noted that delusional depressives, more than any other 
subgroup of patients with endogenous depression, manifest the “distinct quality” of 
dysphoric mood emphasized by many nosologists (e.g., Mendels and Cochrane, 1968). 
This feature was recognized by early clinicians (Kraepelin, 1904, 1921; Gillespie, 1926) 
and was described as a uniquely aversive, anguished, or uncomfortable experience: 
“painful tension, ” “torment” (Kraepelin, 1921); something “formless . . vague and 
very unpleasant in tone. From this arose the difficulty that these patients so frequently 
had in expressing their condition to the physician” (Gillespie, 1926). Because this 
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concept has been difficult to define operationally, it is now usually described as what it 
is not, rather than as what it actually is (see the Research Diagnostic Criteria, for 
example). We regard it as a severe form of the disinhibition of central pain mecha- 
nisms discussed by Donald Klein (Klein and Davis, 1969; Klein, 1974). 
Since pain itself can cause disinhibited HPA activity (Allen et al., 1973), this 
distinctive, though poorly understood “psychic pain” of endogenous depressives may 
be a critical determinant of the abnormal DST responses. The heterogeneity of DST 
responses could then be related to variations firstly in the severity of this clinical 
feature among patients, and secondly in their thresholds for neuroendocrine activa- 
tion by pain mechanisms. 
These two sources of variance, combined with the lack of operational means to 
characterize the experience of “psychic pain,” may well account for the fact that a 
distinctive clinical profile of endogenous depressive patients with abnormal DST 
responses has not yet emerged. The formulation proposed above would be consistent 
also with our findings of a high frequency of abnormal DST responses in two other 
conditions, namely, mixed manic-depressive states and depressed-type schizoaffective 
disorder (Carroll et al., unpublished observations). In both cases a severe dysphoria of 
the distinctive endogenous type is observed. Experimental studies of the HPA 
response to pain among endogenous depressive patients, including the Winokur 
subtypes, are suggested to test these possible sources of variance in DST responses. 
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